[{"Assets_0_FY_USD":8318465000.0,"CIK":"875320","CommonStockSharesConverted_0_FY_shares":258993000.0,"CommonStockSharesOutstanding_0_FY_shares":258993000.0,"Country":"United States","EarningsPerShareBasic_1_FY_USD":2.26,"EarningsPerShareBasic_4_FY_USD":4.58,"EarningsPerShareDiluted_1_FY_USD":2.23,"EarningsPerShareDiluted_4_FY_USD":4.51,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":1569330000.0,"NetIncomeLossConverted_1_FY_USD":583234000.0,"NetIncomeLossConverted_4_FY_USD":1176810000.0,"OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_FY_USD":1413265000.0,"RevenuesConverted_4_FY_USD":4162821000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":6085244000.0,"Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":262108000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":260673000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":258003000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":256728000.0,"filed":"20200213","footnote":"nan","form":"10-K","fp":"FY","fy":"2019.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20191231","qtrs":"0","uom":"USD"}]